WMDIMHO this will go up in no time. Good to bay at the current price not going to be staying long at this price. WEEDMD REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS WeedMD Inc. has released its financial results for the three and nine months ended Sept. 30, 2018. For the quarter ending Sept. 30, 2018, the company reports revenues of $2.0-million, representing a year-over-year increase of 461 per cent. Revenues of $5.2-million in the first nine months of fiscal 2018 represent a 784-per-cent increase compared with the same period during the 2017 fiscal year. "The third quarter was another strong growth period for WeedMD. We increased revenues by more than 450 per cent compared to the prior year and rapidly ramped up production capacity at our state-of-the-art hybrid greenhouse. Through strategic additions to our highly experienced management team, we strengthened our production, sales, marketing and business development capabilities," said Nichola Thompson, interim chief financial officer of WeedMD. "Our fully funded path to more than 500,000 square feet of high-quality, cost-effective cultivation footprint provides us with significant advantages to capitalize on a tight cannabis supply market at the onset of the Canadian adult-use market." "We are exploring opportunities to expand internationally, including having recently supplied our industry-leading cannabis genetics to Israel's Pharmocann and Australia's Medifarm," said Keith Merker, chief executive officer of WeedMD. "As the cannabis industry evolves into increasingly differentiated, high-margin product offerings across the medical and adult-use segments, WeedMD has positioned itself to take full advantage of market opportunities in Canada and internationally."